53 related articles for article (PubMed ID: 30578657)
21. Influence of the Bioactive Diet Components on the Gene Expression Regulation.
Mierziak J; Kostyn K; Boba A; Czemplik M; Kulma A; Wojtasik W
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34835928
[TBL] [Abstract][Full Text] [Related]
22. Recent Advances in Phenolic Metabolites and Skin Cancer.
Pop TD; Diaconeasa Z
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575899
[TBL] [Abstract][Full Text] [Related]
23. The Research on the Treatment of Metastatic Skin Cutaneous Melanoma by Huanglian Jiedu Decoction Based on the Analysis of Immune Infiltration Analysis.
Li D; Li SF; Li XY; Sun XW; Sun TY; Hu GJ
Evid Based Complement Alternat Med; 2021; 2021():9952060. PubMed ID: 34239596
[TBL] [Abstract][Full Text] [Related]
24. Topical Nanoemulgel for the Treatment of Skin Cancer: Proof-of-Technology.
Nagaraja S; Basavarajappa GM; Attimarad M; Pund S
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34207014
[TBL] [Abstract][Full Text] [Related]
25. Chrysin: Perspectives on Contemporary Status and Future Possibilities as Pro-Health Agent.
Stompor-Gorący M; Bajek-Bil A; Machaczka M
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34198618
[TBL] [Abstract][Full Text] [Related]
26. Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin.
Talebi M; Talebi M; Farkhondeh T; Simal-Gandara J; Kopustinskiene DM; Bernatoniene J; Samarghandian S
Cancer Cell Int; 2021 Apr; 21(1):214. PubMed ID: 33858433
[TBL] [Abstract][Full Text] [Related]
27. Antineoplastic Activity of Chrysin against Human Hepatocellular Carcinoma: New Insight on GPC3/SULF2 Axis and lncRNA-AF085935 Expression.
Sherif IO; Al-Mutabagani LA; Sabry D; Elsherbiny NM
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076548
[TBL] [Abstract][Full Text] [Related]
28. Alternative Options for Skin Cancer Therapy via Regulation of AKT and Related Signaling Pathways.
Hwang SY; Chae JI; Kwak AW; Lee MH; Shim JH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962182
[TBL] [Abstract][Full Text] [Related]
29. Chrysin Induced Cell Apoptosis and Inhibited Invasion Through Regulation of TET1 Expression in Gastric Cancer Cells.
Zhong X; Liu D; Jiang Z; Li C; Chen L; Xia Y; Liu D; Yao Q; Wang D
Onco Targets Ther; 2020; 13():3277-3287. PubMed ID: 32368086
[TBL] [Abstract][Full Text] [Related]
30. Flavonoids Distinctly Stabilize Lymph Endothelial- or Blood Endothelial Disintegration Induced by Colon Cancer Spheroids SW620.
Berenda J; Smöch C; Stadlbauer C; Mittermair E; Taxauer K; Huttary N; Krupitza G; Krenn L
Molecules; 2020 Apr; 25(9):. PubMed ID: 32365473
[TBL] [Abstract][Full Text] [Related]
31. NF-kappaB activation in melanoma.
Ueda Y; Richmond A
Pigment Cell Res; 2006 Apr; 19(2):112-24. PubMed ID: 16524427
[TBL] [Abstract][Full Text] [Related]
32. Apoptotic effects of chrysin in human cancer cell lines.
Khoo BY; Chua SL; Balaram P
Int J Mol Sci; 2010 May; 11(5):2188-99. PubMed ID: 20559509
[TBL] [Abstract][Full Text] [Related]
33. Chrysin inhibit human melanoma A375.S2 cell migration and invasion via affecting MAPK signaling and NF-κB signaling pathway in vitro.
Chen HY; Jiang YW; Kuo CL; Way TD; Chou YC; Chang YS; Chung JG
Environ Toxicol; 2019 Apr; 34(4):434-442. PubMed ID: 30578657
[TBL] [Abstract][Full Text] [Related]
34. Phenethyl Isothiocyanate (PEITC) and Benzyl Isothiocyanate (BITC) Inhibit Human Melanoma A375.S2 Cell Migration and Invasion by Affecting MAPK Signaling Pathway
Ma YS; Hsiao YT; Lin JJ; Liao CL; Lin CC; Chung JG
Anticancer Res; 2017 Nov; 37(11):6223-6234. PubMed ID: 29061805
[TBL] [Abstract][Full Text] [Related]
35. Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-κB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro.
Liu JF; Lai KC; Peng SF; Maraming P; Huang YP; Huang AC; Chueh FS; Huang WW; Chung JG
Molecules; 2018 Aug; 23(8):. PubMed ID: 30104528
[TBL] [Abstract][Full Text] [Related]
36. Cantharidin impairs cell migration and invasion of A375.S2 human melanoma cells by suppressing MMP-2 and -9 through PI3K/NF-κB signaling pathways.
Ji BC; Hsiao YP; Tsai CH; Chang SJ; Hsu SC; Liu HC; Huang YP; Lien JC; Chung JG
Anticancer Res; 2015 Feb; 35(2):729-38. PubMed ID: 25667452
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
